Gene · 3806
Papers1,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KIR genes influence endometrial dysbiosis, chronic endometritis and antibiotic response in infertile women. | Reprod Biomed Online | 2026 | 42476044 | PubTator, text mining | PubMed |
| Flow Cytometric Detection of NK Cell KIR Receptors: a Novel Tool for Functional Profiling in Reproductive Failure. | Clin Lab | 2026 | 42411671 | PubTator, text mining | PubMed |
| Outcomes of PTCY-Based Haploidentical Transplants and Donor Factors Affecting Outcomes: A 12-year Experience from India. | Blood Cell Ther | 2026 | 42253351 | PubTator, text mining | PubMed |
| Examining the association between fetal HLA-C, maternal KIR haplotypes and birth weight. | PLoS Genet | 2026 | 42008539 | PubTator, text mining | PubMed |
| Molecular and endocrine differences in early miscarriage associated with KIR polymorphisms in European ancestry women. | Reprod Biomed Online | 2026 | 41980565 | PubTator, text mining | PubMed |
| Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitis. | ERJ Open Res | 2026 | 41809856 | PubTator, text mining | PubMed |
| Integrative Roles of NK Receptors and γδ TCRs in γδ T Cell-Mediated Cancer Immunity. | Immune Netw | 2026 | 41800030 | PubTator, text mining | PubMed |
| Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy. | Pharm Sci Adv | 2026 | 41799416 | PubTator, text mining | PubMed |
| Establishment and Multidimensional Characterization of a Novel Epstein-Barr Virus (EBV)-Negative Human Type I Natural Killer T-Cell Line NKT617. | Lab Invest | 2026 | 41308748 | PubTator, text mining | PubMed |
| Shedding light on the complicated world of alloreactive NK cells. | Haematologica | 2026 | 41230700 | PubTator, text mining | PubMed |
| Crosstalk between decidual natural killer cells and extravillous trophoblasts at the maternal-fetal interface: current status and future perspectives. | Front Immunol | 2025 | 41200190 | PubTator, text mining | PubMed |
| IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy. | Oncoimmunology | 2025 | 40996786 | PubTator, text mining | PubMed |
| Allele Level Sequencing of Killer Cell Immunoglobulin-Like Receptor Genes Using Oxford Nanopore Long Read Sequencing. | HLA | 2025 | 40985045 | PubTator, text mining | PubMed |
| Prediction and effect on relapse of natural killer cell alloreactivity based on KIR-HLA interactions in pediatric haploidentical transplantation with anti-thymoglobulin. | Front Immunol | 2025 | 40934005 | PubTator, text mining | PubMed |
| [Clinicopathological features and prognosis of aggressive natural killer-cell leukemia: an analysis of 27 cases]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 40921665 | PubTator, text mining | PubMed |
| Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants. | Diabetologia | 2025 | 40835749 | PubTator, text mining | PubMed |
| Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editing. | Blood Cancer J | 2025 | 40804254 | PubTator, text mining | PubMed |
| Analyses of peripheral blood NK cells in response to anti-PD-1 therapy in metastatic melanoma patients. | Clin Immunol | 2025 | 40645389 | PubTator, text mining | PubMed |
| RIFINs displayed on malaria-infected erythrocytes bind KIR2DL1 and KIR2DS1. | Nature | 2025 | 40500441 | PubTator, text mining | PubMed |
| Examining the association between fetal HLA-C, maternal KIR haplotypes and birth weight. | medRxiv | 2025 | 40297441 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3806/papers